MBX Biosciences (MBX) Capital Expenditures (2023 - 2026)
MBX Biosciences' Capital Expenditures came in at $901,000 for Q2 2026, up 27.4% from $707,000 a year earlier and up 106.2% from the prior quarter.
Powered by 
Analysis
MBX Biosciences (MBX) Capital Expenditures (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, MBX Biosciences reported Capital Expenditures of $2.53 million, up 185.6% year-over-year; for FY2025, it came in at $1.93 million, up 120.7% from FY2024.
- Going back by year, Capital Expenditures was $874,000 in FY2024 (+577.5%) and $129,000 in FY2023.
- The Q2 2026 figure represents the highest quarterly Capital Expenditures in data going back to Q4 2023.
- Year-over-year, Capital Expenditures increased in five of the last six quarters, with growth averaging 237.3%.
- Business Quant data shows MBX's Capital Expenditures at $437,000 (Q1 2026), $793,000 (Q4 2025) and $399,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 112.20 Mn |
| 10 | MBX Biosciences | 2.57 Bn | 2.57 Bn | - | 901,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 901,000.00 |
| Mar 31, 2026 | 437,000.00 |
| Dec 31, 2025 | 793,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 707,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 452,000.00 |
| Mar 31, 2024 | 273,000.00 |
| Dec 31, 2023 | 55,000.00 |
API Access
MBX Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();